NDC 72789-171 – Lithium Carbonate
Lithium Carbonate 300 mg/1 · Tablet, Extended Release · Oral
Product NDC72789-171
Product details
- Brand name
- Lithium Carbonate
- Generic name
- Lithium Carbonate
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA076832
- Marketed since
- October 28, 2004
- Listing expires
- December 31, 2026
- Pharmacologic class
- Mood Stabilizer
Active ingredients
- Lithium Carbonate 300 mg/1
Uses, dosage, side effects and warnings for Lithium Carbonate →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 72789-171-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-171-01) | Jul 28, 2023 |
| 72789-171-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-171-30) | Jan 4, 2021 |
| 72789-171-82 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-171-82) | Aug 23, 2023 |
Other Lithium Carbonate products
- 62332-148 Lithium Carbonate 300 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 46708-148 Lithium Carbonate 300 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Limited
- 68084-655 Lithium Carbonate 450 mg/1 · Tablet, Extended Release · American Health Packaging
- 68084-640 Lithium Carbonate 300 mg/1 · Tablet, Extended Release · American Health Packaging
- 0054-0020 Lithium Carbonate 450 mg/1 · Tablet, Extended Release · Hikma Pharmaceuticals USA Inc.
- 0054-0021 Lithium Carbonate 300 mg/1 · Tablet, Extended Release · Hikma Pharmaceuticals USA Inc.
- 43063-901 Lithium Carbonate 450 mg/1 · Tablet, Extended Release · PD-Rx Pharmaceuticals, Inc.
- 70518-2086 Lithium Carbonate 450 mg/1 · Tablet, Extended Release · REMEDYREPACK INC.
- 70518-3681 Lithium Carbonate 300 mg/1 · Tablet, Extended Release · REMEDYREPACK INC.
- 70518-0608 Lithium Carbonate 300 mg/1 · Tablet, Extended Release · REMEDYREPACK INC.
- 70518-4678 Lithium Carbonate 450 mg/1 · Tablet, Extended Release · REMEDYREPACK INC.
- 64980-205 Lithium Carbonate 300 mg/1 · Tablet, Extended Release · Rising Pharma Holdings, Inc.